US-UK drug deal could result in 229,000 excess deaths in England, analysis suggests

Analysis of the UK-US drug trade deal indicates it could lead to approximately 229,000 excess deaths in England due to NHS funding being diverted to pay for expensive new medicines. The deal aims to ease tariffs on British drug exports to the US but raises critical health and economic concerns.